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Background: Upright exercise stress echocardiography (SE) induces significant intraventricular gradient (IVG) and
systolic anterior motion (SAM) in a large proportion of symptomatic athletes, who may therefore benefit from a
negative inotropic therapy.
The purpose of the present study was to assess the effect of chronic oral b blocker therapy on the occurrence of
exercise-induced IVG and mitral valve SAM, in symptomatic athletes.
Methods: We enrolled 35 symptomatic athletes (age = 23 ± 11 years) with IVG (>30 mmHg) during SE off therapy.
All repeated SE on chronic oral beta-blocker therapy (atenolol up to 50 mg, bisoprolol up to 10 mg, or metoprolol
up to 100 mg daily according to physician-driven choice).
Results: On therapy, there was during SE a reduction in IVG (35 off vs 17 on beta blocker, p < 0.01), decrease of
IVG (102 ± 34 mmHg off vs 69 ± 24 mmHg on beta blocker, p < 0.01), peak heart rate (178 ± 15 bpm off vs 157 ±
9 bpm on beta blocker), SAM (24 off vs 9 on beta blocker, p < 0.001), symptoms during SE (17 off vs 2 on beta
blocker p < 0.001), ST segment depression (13 off vs 2 on beta blocker, p < 0.001).
Conclusions: In athletes with positive screening on medical evaluation for sports practice and IVG on exertion,
treatment with oral beta blockers improved symptoms in the large majority of patients. Symptomatic benefit was
mirrored by objective evidence of improvement of echocardiographic signs of obstruction (IVG and SAM) and
reduction of ischemia-like electrocardiographic changes.
Introduction
Upright exercise stress echocardiography (SE) induces a
significant intraventricular gradient (IVG) in a large
population of symptomatic athletes [1], but the clinical
implications of this finding remain unclear. Since the
underlying pathophysiological condition is an hyperki-
netic response of the left ventricle, there is rationale for
a targeted negative inotropic therapy with beta-blockers
in these subjects, as it has been previously described in
Syndrome X patients [2]. However, the evidence sup-
porting the initiation, driven by SE results, of a beta-
blocker therapy in athletes is anecdotal to date. The aim
of the present open-label, prospective, non-randomized
study was to provide proof of concept that SE can be a
guide to tailored treatment in athletes with positive
screening [3] on medical evaluation for sports practice,
that develop IVG and mitral valve SAM on exertion.
Methods
Population
We performed SE in 139 A (135 amatheur), 30 (22%) of
whom were female, mean aged 22 ± 9.9 years old (9 to
56), with a positive screening for sports practice but
with normal rest echocardiogram. These athletes were
referred to our center between 2002 and 2010, after the
initial publication [4] of a case report of a runner, who
had a normal rest echocardiogram and normal coronary
arteries and was submitted to an exercise stress test,
during which had developed ischemia and IVG. In
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mean end-systolic peak of 95 ± 35 mmHg (50 to 193),
combined with mitral valve SAM in 33 of them. The 35
pts who repeated the SE under treatment with b block-
ers are the study group. Two (6%) of them were women.
Mean age was 23 ± 11 years old (11 to 56). Thirty three
had exercise related symptoms or positive exercise
electrocardiography.
Exclusion criteria were the presence of left ventricular
(LV) hypertrophy, mitral valve prolapse or other valvular
disease. At the time of the second SE assessment all
athletes were medicated with beta-blockers. In all cases,
beta-blockers were taken at breakfast on the morning of
the exam, and had been prescribed by the patients’ physi-
cians: metoprolol 100 mg (in two athletes), atenolol 50 mg
in one athlete and bisoprolol in 32 athletes (2.5 mg in two,
10 mg in one and 5 mg in 29 athletes). Bisoprolol was
started with 1.25 mg once daily in pediatric age and with
2.5 mg in the adults and was titrated to the maximum
tolerated dose or until clinical benefit was seen.
The study protocol was approved by the Ethics Com-
mittee at Garcia de Orta Hospital and conforms to the
ethical guidelines of the 1975 Declaration of Helsinki. All
athletes or parents gave informed consent for the study.
Exercise stress echocardiography
A complete echocardiographic assessment was per-
formed, including measurement of the LV outflow tract
and calculation of the index, LV mass index, relative
wall thickness, and LV end-diastolic volume.
Maximum flow velocity was also assessed by continu-
ous wave Doppler in the LV outflow tract in five-cham-
ber apical view to calculate the intra-ventricular
gradient.
The athletes had previously undergone exercise stress
echocardiography without beta-blockers, and subse-
quently repeated the exam under beta-blocker therapy
during the following year. The methodology used [5]
included assessment of wall motion during treadmill
exercise, as well as of flows by pulsed and continuous
wave Doppler for detection of IVG and color Doppler.
Mitral valve motion is also assessed, particularly for
SAM. The exams were recorded on video in their
entirety, with parts recorded on optical disk.
A significant intra-ventricular gradient was considered
if greater then 30 mmHg during/immediately after
stress, at the end of systole.
The Doppler echocardiographic parameters presented
are the mean of three measurements obtained on conse-
cutive, good-quality recordings.
Ergometric parameters
The following parameters were assessed during SE: test
duration (in seconds), systolic blood pressure at rest and
at peak exercise, heart rate at rest and at peak exercise,
peak double product, and occurrence of ST segment
alterations - ST depression of 1 mm 80 ms after the J
point. Occurrence of symptoms during the test similar
to those that prompted the patients’ original assessment
was also recorded.
Statistical analysis
The results are presented as means ± standard deviation
for continuous variables, and frequencies and percen-
tages for categorical variables. The comparison between
the two assessments was performed by using the Stu-
dent’s t test for continuous variables and the McNemar
test for paired samples for nominal qualitative data.
Results
Of the 35 athletes enrolled in the study, two (6%) were
women. Mean aged was 23 ± 11 years old (11 to 56).
Fifteen athletes practice athletics, eleven practice soccer,
and the other nine, other sports - diving (1), tennis (1),
basketball (1), swimming (2), rowing (1), handball (2),
karate (1). The initial evaluation was done due to dizzi-
ness in fourteen athletes, chest pain in eight athletes,
palpitations in four athletes, exercise stress electrocar-
diography with ST alterations in seven athletes, ECG
repolarization alterations in one athlete and documented
ventricular premature complexes in one athlete. On the
resting echocardiogram, at the first assessment, LV out-
flow tract index was 10.6 ± 0.9 mm/m2, IVS index was
5.2 ± 0.67 mm/m
2, PW index was 4.73 ± 0.47 mm/m
2,
LV end-diastolic diameter index was 26.21 ± 1.96 mm/m
2,
LV mass index was 76.6 ± 10.6 g/m2, relative wall
thickness was 0.36 ± 0.03, and LV end-diastolic volume
w a s4 6 . 3±7 . 3m l / m
2.N ow a l lm o t i o na b n o r m a l i t i e s
were detected in any of the exams, with or without beta
blockers. IVG at peak exercise on the first assessment
was 102 ± 34 mmHg. Thirty athletes (85%) showed
improvement and are doing well at the moment of the
second SE. The main results of the variables studied are
shown in Table 1. The inclusion criterion was the pre-
sence of IVG in the first SE. The evaluation by Doppler
echocardiography was feasible in the whole study popula-
tion. We should note that the Doppler evaluation was
done during/immediately after stress, in orthostatic posi-
tion and then in left lateral decubitus. The Doppler
evaluation was possible during exercise (at peak) in
33 (94%) and in all the athletes immediately after stress.
Discussion
Intra-ventricular gradients in a symptomatic patient
were first described by Lau et al [6], who detected the
phenomenon in a patient with effort angina and treated
it with bisoprolol, resulting in clinical improvement and
a significant reduction in the IVG.
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IVG in patients with angina and angiographically normal
coronary arteries [4] which led to a study of 91 syn-
drome X patients [7], among whom we selected 20
patients, with IVG, that were treated with beta blocker,
with symptomatic benefit [2].
Particular problems arise when treating athletes in
pediatric age - as were 15 (43%) athletes of this study -
because beta blockers are used following extrapolation
from data obtained with studies in adults. The most
obvious problem is that the dose range will not have
been established during drug development. The laws
and the regulatory processes that govern the pharma-
ceutical industry have historically led to exclusion of
children from the drug development process. However,
clinical benefit of beta blockers use, in children with left
ventricular outflow obstructive pathology, has been
shown [8,9]. The benefit of beta blockers in the treat-
ment of symptoms possibly related to IVG elicited by
exercise, in patients without hypertrophic cardiomyopa-
thy [2,10,11], has been showed before and so we decided
to use them also in children.
In our study we found that beta blockers reduced
heart rate, ST-segment alterations during exercise, systo-
lic blood pressure and hence peak HRxSBP. The occur-
rence of IVG (Figure 1) and SAM (Additional file 1) on
exertion also decreased significantly ((Additional file 2).
These changes were accompanied by improvement in
symptoms during exercise testing and follow-up.
In the present study there was improvement in symp-
toms, however the functional capacity continued the
same. This fact favors the present legislation that doesn’t
consider illegal the use of beta blockers in the majority of
sports practiced by the athletes that were included [12].
The relation between IVG and symptoms or ST
alterations during exercise stress electrocardiography
has been demonstrated previously [1,4,6,7]. Is also of
importance the fact that the two studies [13,14] that
searched IVG in healthy people have failed to found
them. This fact reinforces the probable pathologic sig-
nificance of exercise induced IVG [15].
The results of this study suggest that exercise stress
echocardiography in orthostatic position in treadmill
would help in selecting symptomatic athletes with posi-
tive screening on medical examination for sports prac-
tice, who develop IVG on exertion and who would
respond particularly well to these drugs. A randomized
study is needed to demonstrate that our practice of
searching for IVG, and treatment with beta blockers, in
athletes with positive screening should be generalized in
clinical practice.
It is established [16] that sem i - s u p i n ee x e r c i s ee c h o -
cardiography is more feasible than treadmill however to
t h eb e s to fo u rk n o w l e d g et h e r ei sn os t u d yd i r e c t l y
comparing the two methods for the evaluation of the
same patients and the same Doppler parameters.
Study Limitations
One limitation of the study is the relatively small sample
size. However, the 35 patients met stringent inclusion
criteria, since all of them were symptomatic athletes
with objective evidence of IVG during exercise, and
therefore represent a selected cohort which is the most
likely candidate to benefit from a targeted therapy with
beta-blockers. As a further limitation, we did not per-
form a randomization with double-blinding of subjects
and investigators for obvious ethical, feasibility and cost
reasons. In our open-label design, both athletes and
investigators were aware of the therapy in progress, and
beta-blocker type and dosage varied widely reflecting
the garden variety of treatment in the real world. In
addition, all tests under therapy were performed at the
second assessment, which may have per se influenced
the results, particularly treadmill test duration and how
the athletes rated their symptoms. However, this would
not influence objective parameters such as the presence
and severity of IVG, which was the study primary end-
point. Further studies, preferably placebo-controlled ran-
domized trials, are needed at this point in order to
assess conclusively the potential benefits for beta block-
ers use in these athletes. The present lack of recommen-
dations for the searching of IVG during exercise in
athletes with positive screening and about the treatment
of these patients with beta blockers further underscore
the importance of additional studies.
Conclusions
In athletes with positive screening - mostly by symp-
toms - on medical evaluation for sports practice and
IVG on exertion, treatment with oral b blockers pre-
vented the occurrence of IVG and SAM or significantly
reduced its magnitude. These changes were associated
Table 1 Variables assessed in the two stress
echocardiograms
SE1 SE2 p
Test duration (sec) 762 ± 107 750 ± 86 0,236
Peak exercise HR (bpm) 179 ± 15 157 ± 9 <0,001
Peak exercise SBP (mmHg) 164 ± 20 155 ± 19 <0,001
Peak exercise DP (HRxSBPPeak) 29424 ± 3746 22798 ± 16170 <0,001
Symptoms during SE (n) 17/35 (49%) 2/35(5.5%) <0.001
Peak IVG (n) 35/35(100%) 17/35(49%) <0.001
SAM (n) 24/35 (69%) 9/35 (26%) <0.001
ST - segment alterations (n) 13/35 (37%) 2/35(5.7%) <0.001
DP: double product; HR: heart rate; IVG: intra-ventricular gradient; SAM: mitral
valve systolic anterior motion; SBP: systolic blood pressure; SE: stress
echocardiography
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and mirrored clinical improvement occurring in 85% of
the study population.
Exercise echocardiography represents a useful tool to
evaluate athletes with positive screening and normal rest
echocardiogram and may permit to select them for beta
blocker therapy. The finding of this study represents a
proof-of-concept of possibility to tailor effective beta-
blocker therapy, driven by exercise-Doppler echocardio-
graphy results, in symptomatic athletes.
Additional material
Additional file 1: Echocardiographic images obtained at peak
exercise in first SE in one athlete of the study, without treatment.
Apical four and five chamber view obtained in apical window during
exercise containing two dimensional data with SAM of mitral valve
Additional file 2: Echocardiographic images obtained at peak
exercise in the second SE in one athlete of the study, under
treatment with beta blocker. Apical four and five chamber view
obtained in apical window during exercise containing two dimensional
data without SAM of mitral valve
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Figure 1 IVG in one athlete assessed before (left) and after (right) - beta blocker therapy
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